John P. Hamill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John P. Hamill
Earlier roles on record: CFO at Windtree Therapeutics Inc /De/ (WINT) until January 27, 2023. Windtree Therapeutics Inc /De/ reported in an 8-K filed January 19, 2023 that John P. Hamill resigned as Senior Vice President, Chief Financial Officer and Corporate Secretary, effective January 27, 2023. The proxy statement of Windtree Therapeutics Inc /De/ reports total compensation of $561,076 for John P. Hamill in fiscal 2022, including a base salary of $398,017. Disclosed compensation is on record for 3 fiscal years.
“On January 17, 2023, John P. Hamill, the Senior Vice President, Chief Financial Officer and Corporate Secretary of Windtree Therapeutics, Inc. (the "Company") notified the Company of his decision to resign effective as of January 27, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-01-27
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Windtree Therapeutics Inc /De/ (WINT) | — | $398,017 | $561,076 |
| 2021 | Windtree Therapeutics Inc /De/ (WINT) | — | $380,175 | $743,204 |
| 2020 | Windtree Therapeutics Inc /De/ (WINT) | — | $167,014 | $1,477,705 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.